Navigation Links
Reportlinker Adds Product Profiles: Multiple Sclerosis - Gilenya Raises Bar for New Market Entrants

rologists prescribe Gilenya because of its strong efficacy in treatment resistant patients as well as its convenient oral mode of administration. However, long term cancer and infection risk remain the main concerns.

The multiple sclerosis market has been lucrative for drug companies over the last decade with limited competition and periodic price increases. However, as this dynamic is changing with increased competition, existing players are expanding their portfolios with new and improved therapies.

Monoclonal antibodies have demonstrated potent efficacy in Phase II trials, surpassing all existing therapies. However, excitement is tempered with safety concerns that include risk of malignancy and severe infections. Still, as seen with Tysabri, impressive efficacy may outweigh the risks for more severe multiple sclerosis patients.

Your key questions answered

* How well do agents in late-stage development for multiple sclerosis compare to one another and the current standard of care?

* What is the most promising treatment in development for multiple sclerosis?

* How do US neurologists perceive Gilenya and key pipeline agents as new treatments of multiple sclerosis?

Executive Summary

Strategic scoping and focus

Datamonitor key findings

Related reports





Product overview

Datamonitor's assessment summary


Gilenya (fingolimod; Novartis/Mitsubishi Tanabe Pharma)

Drug profile

Development overview

SWOT analysis

Satisfaction of unmet needs

Product positioning

Physician perception of Gilenya

Clinical and commercial attractiveness

Avonex (interferon beta-1a; Biogen Idec)

Drug profile

Development overview

SWOT analysis

Satisfaction of unmet needs

Product positioning

Clinical and commerci

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
(Date:10/9/2015)... 2015 Adheron Therapeutics, a privately held ... , United States , ... acquired by Roche.  Adheron Therapeutics has developed a ... a cell surface protein called Cadherin-11 in order ... inflammatory and autoimmune diseases such as rheumatoid arthritis ...
(Date:10/8/2015)... , October 9, 2015 ... or diagnostic colonoscopy. The NOCT study also assessed ... NER1006. --> ® ) in adult ... NOCT study also assessed the compliance, safety, patient ... Norgine today announced positive top line results for ...
(Date:10/8/2015)... 8, 2015  Trovagene, Inc., (NASDAQ:   TROV) ... the presentation of results from a field experience ... Monitoring SM (PCM) platform to accurately identify ... to determine appropriate therapy for patients. Mark ... is delivering the results today in an oral ...
Breaking Medicine Technology:
... Va., Aug. 8, 2011 Science Applications International ... has completed the acquisition of Vitalize Consulting Solutions ... and information technology (IT) services for healthcare enterprises. ... the commercial hospital market that are implementing electronic ...
... HOPKINTON, Mass., Aug. 8, 2011 Caliper Life Sciences, ... it has favorably settled two lawsuits with Carestream Health, ... February 2010, Caliper, its wholly owned subsidiary, Xenogen, and ... its instrument systems induced infringement of seven imaging patents ...
Cached Medicine Technology:
(Date:10/9/2015)... Orleans, LA (PRWEB) , ... October 09, 2015 ... ... with offices serving New Orleans and the surrounding communities, is initiating a combined ... and medical care for unwanted animals in southern Louisiana. , Animal Rescue ...
(Date:10/9/2015)... TN (PRWEB) , ... October 09, 2015 , ... Santa ... announce their partnership as MD Anderson prepares to go-live on the Epic platform in ... planned for early 2016. Santa Rosa will execute the contract by supporting Scheduling Appointment ...
(Date:10/9/2015)... ... October 09, 2015 , ... Smanos was featured on ... technology products available to consumers. Scott Steinberg, a technology expert and special reporter for ... for any home or dorm. , In this day and age it’s more important ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... Kimberly Post, CPA , as Chief Financial Officer. Kimberly will provide ... and assist with any strategic acquisitions. Kimberly’s experience guiding healthcare services organizations ...
(Date:10/9/2015)... Evanston, IL (PRWEB) , ... October 09, 2015 , ... ... lanyards for participants, volunteers, staff, and members of the media at the annual ... athletes will participate in the 140.6 mile triathlon, which has taken place in Hawaii ...
Breaking Medicine News(10 mins):
... robotics the latest is that of the development of an analog ... as that of tentacles or an elephant trunk. // It is ... of objects. Initially the robots could not do this and rely ... holding large or irregularly shaped objects. , But now ...
... is one of a new generation drug that can treat breast ... patients suffering from later stages of breast cancer. // Due to ... force their local health care providers to pay for the drug. ... case and won it. He was told that his local NHS ...
... was surprising to find that young people in the UK are ... // People between the age group of 15-24 years avoid using ... a result of observing the National Condom Week (NAT) health officials ... British students. ,It surveyed 2,048 people aged 15 and ...
... be allowed to use IVF to have children free of ... discussed by the government's fertility watchdog tomorrow for approval. // ... to select embryos free from genes that can cause the ... and Embryology Authority (HFEA) would permit thousands of women who ...
... markets witnessed large scale slaughtering of chicken, ... outbreak in the West African country of ... also imposed a ban on the entry ... part of West Africa. ,The infected ...
... Researchers have established that white blood cells, derived from ... can be exploited// in the development of novel forms ... other mice with cancer, it was found to confer ... ,This study for the first time highlights the presence ...
Cached Medicine News:
Foldable Hydrophilic IOL with UV Absorber....
Foldable Silicone Multi-piece Lens....
... indicated for the visual correction in persons ... whom a cataract lens has been removed. ... made from proprietary silicone material. The exclusive ... reflections and to facilitate capsular contact. It ...
... & Lomb PMMA Posterior Chamber Intraocular Lenses are ... the visual correction of aphakia in patients 60 ... lens has been removed by extracapsular extraction methods. ... the ciliary sulcus or capsular bag. Lenses with ...
Medicine Products: